Get the Stockscreener App
3.15
3.08%
-0.10
After Hours:
3.21
0.06
+1.90%
Sera Prognostics Inc stock is traded at $3.15, with a volume of 25,242.
It is down -3.08% in the last 24 hours and down -0.63% over the past month.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
See More
Previous Close:
$3.25
Open:
$3.23
24h Volume:
25,242
Relative Volume:
0.26
Market Cap:
$115.62M
Revenue:
$306.00K
Net Income/Loss:
$-36.24M
P/E Ratio:
-2.7155
EPS:
-1.16
Net Cash Flow:
$-27.32M
1W Performance:
+6.78%
1M Performance:
-0.63%
6M Performance:
-7.08%
1Y Performance:
-53.19%
1-Day Range:
$3.13
$3.292
1-Week Range:
$2.891
$3.292
52-Week Range:
$1.37
$9.1297
Sera Prognostics Inc Stock (SERA) Company Profile
Name
Sera Prognostics Inc
Sector
Industry
Phone
(801) 990-0520
Address
2749 E. PARLEYS WAY, SALT LAKE CITY
Compare SERA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SERA
Sera Prognostics Inc
|
3.15 | 123.70M | 306.00K | -36.24M | -27.32M | -1.16 |
|
ABT
Abbott Laboratories
|
134.27 | 231.52B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
SYK
Stryker Corp
|
375.29 | 141.16B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
BSX
Boston Scientific Corp
|
96.79 | 142.10B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
MDT
Medtronic Plc
|
97.87 | 126.13B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
75.74 | 45.04B | 5.69B | 1.41B | 577.90M | 6.9828 |
Sera Prognostics Inc Stock (SERA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-30-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | Oppenheimer | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
Sera Prognostics Inc Stock (SERA) Latest News
What analysts say about Sera Prognostics Inc stockValue Stock Picks & High Profit Trading Signals - earlytimes.in
Will Sera Prognostics Inc. continue its uptrendEarnings Beat & Technical Buy Zone Confirmation - newser.com
Identifying reversal signals in Sera Prognostics Inc.Weekly Stock Summary & High Conviction Buy Zone Picks - newser.com
What Fibonacci levels say about Sera Prognostics Inc. reboundTrade Exit Summary & AI Based Buy and Sell Signals - newser.com
Is Sera Prognostics Inc. stock cheap at current valuationJuly 2025 Institutional & Intraday High Probability Alerts - newser.com
How buybacks impact Sera Prognostics Inc. stock valueWeekly Market Summary & Fast Entry and Exit Trade Plans - newser.com
Pattern recognition hints at Sera Prognostics Inc. upsideJuly 2025 Institutional & Stepwise Swing Trade Plans - newser.com
Will a bounce in Sera Prognostics Inc. offer an exitPortfolio Value Summary & Weekly High Momentum Picks - newser.com
Should you wait for a breakout in Sera Prognostics Inc.July 2025 PreEarnings & Long-Term Capital Growth Strategies - newser.com
Tools to assess Sera Prognostics Inc.’s risk profileWeekly Gains Report & Smart Swing Trading Techniques - newser.com
Sera Prognostics appoints Dr. Tiffany Inglis as chief medical officer By Investing.com - Investing.com Nigeria
Sera Prognostics appoints Dr. Tiffany Inglis as chief medical officer - Investing.com
Women's Health Pioneer Sera Prognostics Taps OBGYN Leader Dr. Inglis to Drive PreTRM Test Adoption - Stock Titan
Detecting support and resistance levels for Sera Prognostics Inc.Weekly Investment Summary & AI Optimized Trading Strategy Guides - newser.com
Goldman Sachs Group Inc. Has $232,000 Position in Sera Prognostics, Inc. $SERA - Defense World
Sera Prognostics Inc Stock (SERA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sera Prognostics Inc Stock (SERA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Mirza Mansoor Raza | Director |
Oct 06 '25 |
Sale |
3.16 |
227 |
717 |
58,253 |
0.65%
1.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):